玖玖资源网站,爆乳久久久,日韩精品乱码久久久蜜桃,精品呦国产一区二区三区,国产伦高清一区二区三区,sese一区二区,午夜精品福利一区二区三区,三级黄色网站久久免费

首頁
訂購/客服:400-666-5481

LY2801653

    
99.8%

LY2801653

源葉(MedMol)
S81233 一鍵復制產品信息
1206799-15-6
C30H22F2N6O3
552.53
L1X; N-(3-fluoro-4-((1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl)oxy)phenyl)-1-(4-fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide; QCR-139;
貨號 規格 價格 上海 北京 武漢 南京 購買數量
S81233-5mg
99.8% ¥500.00 5 - - -
S81233-10mg
99.8% ¥800.00 4 - - -
S81233-25mg
99.8% ¥1350.00 5 - - -
S81233-100mg
99.8% ¥3500.00 3 - - -
產品介紹 參考文獻 質檢證書(COA) 摩爾濃度計算器 相關產品

產品介紹

Merestinib (LY2801653) is a potent, orally bioavailable c-Met inhibitor (Ki=2 nM) with anti-tumor activities. Merestinib (LY2801653) also has potent activity against MST1R (IC50=11 nM), FLT3 (IC50=7 nM), AXL (IC50=2 nM), MERTK (IC50=10 nM), TEK (IC50=63 nM), ROS1, DDR1/2 (IC50=0.1/7 nM) and MKNK1/2 (IC50=7 nM)

產品描述: Merestinib (LY2801653) is a potent, orally bioavailable c-Met inhibitor (Ki=2 nM) with anti-tumor activities. Merestinib (LY2801653) also has potent activity against MST1R (IC50=11 nM), FLT3 (IC50=7 nM), AXL (IC50=2 nM), MERTK (IC50=10 nM), TEK (IC50=63 nM), ROS1, DDR1/2 (IC50=0.1/7 nM) and MKNK1/2 (IC50=7 nM)
靶點: Ki: 2 nM (c-Met) IC50: 11 nM (MST1R), 7 nM (FLT3), 2 nM (AXL), 10 nM (MERTK), 63 nM (TEK), 0.1/7 nM (DDR1/2), 7 nM (MKNK1/2);DiscoidinDomainReceptor(DDR);?FLT;?c-Met/HGFR;?ROS;?ROSKinase
體內研究: Merestinib (LY2801653) demonstrates anti-tumor effects in MET amplified (MKN45), MET autocrine (U-87MG, and KP4) and MET over-expressed (H441) xenograft models; and in vivo vessel normalization effects. Merestinib (LY2801653) is a type-II ATP competitive, slow-off inhibitor of MET tyrosine kinase with a pharmacodynamic residence time (Koff) of 0.00132 min-1?and t1/2?of 525 min. Merestinib (LY2801653) treatment inhibits MET phosphorylation with a composite TED50 (50 % target inhibition dose) of 1.2 mg/kg and a composite TED90 (90 % target inhibition dose) of 7.4 mg/kg. Merestinib (LY2801653) (20 mg/kg) reduces TFK-1 tumor growth significantly relative to vehicle control. Merestinib (LY2801653) inhibits the growth of intra- and extrahepatic CCC xenograft tumors.
參考文獻: 1. Yan SB, et al. LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models. Invest New Drugs. 2013 Aug;31(4):833-44. 2. Barat S, et al. Targeting c-MET by LY2801653 for treatment of cholangiocarcinoma. Mol Carcinog. 2016 Jan 12.
溶解性: DMSO  :  ≥  32  mg/mL  (57.92  mM)
保存條件: -20℃
配置溶液濃度參考:
1mg 5mg 10mg
1 mM 1.81 ml 9.049 ml 18.099 ml
5 mM 0.362 ml 1.81 ml 3.62 ml
10 mM 0.181 ml 0.905 ml 1.81 ml
50 mM 0.036 ml 0.181 ml 0.362 ml
注意: 部分產品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。

參考文獻

質檢證書(COA)

如何獲取質檢證書(COA)?
請輸入貨號和一個與之匹配的批號。
例如:
批號:JS298415 貨號:S20001-25g
在貨品標簽上如何找到貨號和批號?

摩爾濃度計算器

質量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

=
×
×
主站蜘蛛池模板: 兰西县| 沂水县| 武穴市| 且末县| 台北县| 镇赉县| 昂仁县| 莎车县| 嘉义市| 富平县| 浦江县| 孟州市| 桦甸市| 南城县| 蒙阴县| 赤峰市| 塔河县| 额敏县| 贵德县| 蓝田县| 乌海市| 北碚区| 福安市| 阳原县| 凭祥市| 昔阳县| 开江县| 临漳县| 彰化市| 呼和浩特市| 新宁县| 富民县| 拉孜县| 金阳县| 灵台县| 蓬莱市| 大渡口区| 格尔木市| 和龙市| 汕尾市| 姚安县|